TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock

Shock

Volumn 25, Issue 4, 2006, Pages 351-357

  Colo Brunialti, Milena Karina ^a   Martins, Paulo Sergio ^a   De Carvalho, Heraclito Barbosa ^b   Machado, Flavia Ribeiro ^a   Barbosa, Leandro Martins ^c   Salomao, Reinaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL SANTA MARCELINA   (Brazil)

Author keywords

IL 10; IL 6; Immunophenotyping; LPS; TNF ; Toll like receptor

Indexed keywords

CD11B ANTIGEN; CELL SURFACE RECEPTOR; CYTOKINE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFECTION CONTROL; INFLAMMATION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; SEPSIS; SEPTIC SHOCK;

ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD14; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; SEPSIS; SHOCK, SEPTIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 33646813341     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000217815.57727.29     Document Type: Article

References (38)

1. Salomao R, Rigato O, Pignatari AC, Freudenberg MA, Galanos C: Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives. Infection 27:1-11, 1999.
2. Freudenberg MA, Salomao R, Sing A, Mitov I, Galanos C: Reconciling the concepts of endotoxin sensitization and tolerance. Prog Clin Biol Res 397:261-268, 1998.
3. Matsuura M, Galanos C: Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium. Infect Immun 58:935-937, 1990.
4. Bartholeyns J, Freudenberg M, Galanos C: Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun 55:2230-2233, 1987.
5. Johnston CA, Greisman SE: In Hinshaw LB (ed.): Handbook of endotoxin. Pathophysiology of endotoxin, Vol. 1. New York, United States of America: Elsevier, p 359, 1985.
6. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150, 2003.
7. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995.
8. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991.
9. Rigato O, Salomao R: Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 19:113-116, 2003.
10. Salomao R, Brunialti MK, Kallas EG, Martins PS, Rigato O, Freudenberg M: Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients. J Endotoxin Res 8:371-379, 2002.
11. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomao R: Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 20:208-212, 2003.
12. Trautinger F, Hammerle AF, Poschl G, Micksche M: Respiratory burst capability of polymorphonuclear neutrophils and TNF-alpha serum levels in relationship to the development of septic syndrome in critically ill patients. J Leukoc Biol 49:449-454, 1991.
13. Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CG, Tervaert JW: Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 26:883-892, 2000.
14. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 365:63-78, 2005.
15. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 406:782-787, 2000.
16. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 17:1-14, 2005.
17. Durieux JJ, Vita N, Popescu O, Guette F, Calzada-Wack J, Munker R, Schmidt RE, Lupker J, Ferrara P, Ziegler-Heitbrock HW, Labeta MO: The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol 24:2006-2012, 1994.
18. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN: CD11b/CD18 acts in concert with CD14 and toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166:574-581, 2001.
19. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 97:13766-13771, 2000.
20. Kalis C, Kanzler B, Lembo A, Poltorak A, Galanos C, Freudenberg MA: Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur J Immunol 33:798-805, 2003.
21. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, et al: Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164:3476-3479, 2000.
22. Tamandl D, Bahrami M, Wessner B, Weigel G, Ploder M, Furst W, Roth E, Boltz-Nitulescu G, Spittler A: Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20:224-229, 2003.
23. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481-1483, 1992.
24. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26:1793-1800, 1998.
25. Galanos C, Freudenberg MA, Luderitz O, Rietschel ET, Westphal O: Chemical, physicochemical and biological properties of bacterial lipopolysaccharides. Prog Clin Biol Res 29:321-332, 1979.
26. Wittebole X, Coyle SM, Kumar A, Goshima M, Lowry SF, Calvano SE: Expression of tumour necrosis factor receptor and toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating. Clin Exp Immunol 141:99-106, 2005.
27. Adib-Conquy M, Moine P, Asehnoune K, Edouard A, Espevik T, Miyake K, Werts C, Cavaillon JM: Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med 168:158-164, 2003.
28. Harter L, Mica L, Stocker R, Trentz O, Keel M: Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22:403-409, 2004.
29. Tsujimoto H, Ono S, Majima T, Kawarabayashi N, Takayama E, Kinoshita M, Seki S, Hiraide H, Moldawer LL, Mochizuki H: Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 23:39-44, 2005.
30. Calvano JE, Agnese DM, Um JY, Goshima M, Singhal R, Coyle SM, Reddell MT, Kumar A, Calvano SE, Lowry SF: Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 20:415-419, 2003.
31. Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB: Differential expression of toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136:312-319, 2004.
32. Hiki N, Berger D, Prigl C, Boelke E, Wiedeck H, Seidelmann M, Staib L, Kaminishi M, Oohara T, Beger HG: Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. Infect Immun 66:1135-1141, 1998.
33. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 9:517-524, 2003.
34. Sekine K, Fujishima S, Aikawa N: Plasma hepatocyte growth factor is increased in early-phase sepsis. J Infect Chemother 10:110-114, 2004.
35. Brunialti MK, Kallas EG, Freudenberg M, Galanos C, Salomao R: Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood. Cytometry 50:14-18, 2002.
36. Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S: Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 165:7096-7101, 2000.
37. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, Bauerle PA, Haas JG, Riethmuller G: Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269:17001-17004, 1994.
38. Adib-Conquy M, Adrie C, Moine P, Asehnoune K, Fitting C, Pinsky MR, Dhainaut JF, Cavaillon JM: NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 162:1877-1883, 2000.